
    
      Healthy controls (n=38), patients with CHD (n=39), periodontitis (n=40), and a combination of
      periodontitis + CHD (n=38) were enrolled in the present study. The analyzed sample undergo a
      demographical, clinical and periodontal evaluation and serological analyses including
      Endothelin-1 (ET-1) and for serum and salivary Galectin-3 levels.
    
  